CornerCap Investment Counsel »

Tenaya Therapeutics shares owned by CornerCap Investment Counsel

Quarter-by-quarter ownership of Tenaya Therapeutics (TNYA) shares owned by CornerCap Investment Counsel from 13F filings

Historical chart of CornerCap Investment Counsel investment in Tenaya Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenaya Therapeutics held by CornerCap Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenaya Therapeutics by CornerCap Investment Counsel

Quarter filed Position value Share count Share price at filing
2023-12-31 $263k 81k 3.24
2023-09-30 $88k 34k 2.55
2023-06-30 $205k 35k 5.87

More positions owned by CornerCap Investment Counsel

Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Cisco Systems (CSCO)
Apple (AAPL)
CSX Corporation (CSX)
Microsoft Corporation (MSFT)
Emerson Electric (EMR)
Merck & Co (MRK)
Booking Holdings (BKNG)
Fnf (FNF)
Bristol Myers Squibb (BMY)
Intel Corporation (INTC)

View all positions for CornerCap Investment Counsel

Top funds holding Tenaya Therapeutics

Column Group
Casdin Capital
RA Capital Management
T. Rowe Price Associates
Vanguard Group
Citadel Advisors
Euclidean Capital
Alphabet
Millennium Management
GSA Capital Partners
TD Asset Management
Bank of New York Mellon
Two Sigma Investments
Bank of America Corporation
Squarepoint Ops

View all funds holding Tenaya Therapeutics